These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24238354)

  • 1. Among disparate views, scales tipped by the ethics of system integrity.
    Schatman ME; Darnall BD
    Pain Med; 2013 Nov; 14(11):1629-30. PubMed ID: 24238354
    [No Abstract]   [Full Text] [Related]  

  • 2. Better late than never: time to up-schedule hydrocodone combination products.
    Kolodny A
    Pain Med; 2013 Nov; 14(11):1627-8. PubMed ID: 24238352
    [No Abstract]   [Full Text] [Related]  

  • 3. The downside of upscheduling.
    Gudin J; Lee AJ
    Pain Med; 2013 Nov; 14(11):1628-9. PubMed ID: 24238353
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA committee: More restrictions needed on hydrocodone combination products.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):862. PubMed ID: 23462764
    [No Abstract]   [Full Text] [Related]  

  • 5. Upscheduling of hydrocodone: convenience and access vs patient safety measures.
    Schatman ME; Darnall BD
    Pain Med; 2013 Nov; 14(11):1627. PubMed ID: 24238351
    [No Abstract]   [Full Text] [Related]  

  • 6. Rescheduling of combination hydrocodone products: problems for long-term care practitioners.
    Mattingly Ii TJ
    Consult Pharm; 2015 Jan; 30(1):13-9. PubMed ID: 25591027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocodone rescheduling.
    Wroten D
    J Ark Med Soc; 2014 Nov; 111(6):100. PubMed ID: 25654919
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA panel recommends tighter rules for prescribing opioids.
    McCarthy M
    BMJ; 2013 Feb; 346():f1012. PubMed ID: 23412738
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of once-daily, extended-release hydrocodone in individuals previously receiving hydrocodone/acetaminophen combination therapy for chronic pain.
    Bartoli A; Michna E; He E; Wen W
    Postgrad Med; 2015 Jan; 127(1):5-12. PubMed ID: 25526227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do we prescribe Vicodin?
    Moore PA; Dionne RA; Cooper SA; Hersh EV
    J Am Dent Assoc; 2016 Jul; 147(7):530-3. PubMed ID: 27350643
    [No Abstract]   [Full Text] [Related]  

  • 11. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
    Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
    Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA to propose hydrocodone reclassification.
    J Calif Dent Assoc; 2014 Jan; 42(1):10. PubMed ID: 25080676
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management.
    Singla A; Sloan P
    J Opioid Manag; 2013; 9(1):71-80. PubMed ID: 23709306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internet-based survey of nonmedical prescription opioid use in the United States.
    Katz N; Fernandez K; Chang A; Benoit C; Butler SF
    Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEA reschedules hydrocodone combination products.
    Pergolizzi JV
    Pain Pract; 2015 Feb; 15(2):95-7. PubMed ID: 25639283
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic analgesics for dental pain: available products, strengths, and formulations.
    Wynn RL
    Gen Dent; 2001; 49(2):126-8, 130, 132 passim. PubMed ID: 12004688
    [No Abstract]   [Full Text] [Related]  

  • 17. Pain & opioid addiction: hydrocodone update & zohydro. The paradigm for the epidemic..... continues.
    Hall PB
    W V Med J; 2014; 110(6):6-10. PubMed ID: 25651658
    [No Abstract]   [Full Text] [Related]  

  • 18. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

  • 19. Rescheduling of hydrocodone combination products: potential impact and alternatives for postoperative pain management.
    Golembiewski J
    J Perianesth Nurs; 2015 Jun; 30(3):244-8. PubMed ID: 26003773
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users.
    Harris SC; Cipriano A; Colucci SV; Kapil RP; Geoffroy P; Hopyan T; Levy-Cooperman N
    Pain Med; 2016 May; 17(5):820-31. PubMed ID: 26814240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.